SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-182056
Filing Date
2021-06-04
Accepted
2021-06-04 07:36:31
Documents
14
Period of Report
2021-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d189824d8k.htm   iXBRL 8-K 28012
2 EX-99.1 d189824dex991.htm EX-99.1 11359
6 GRAPHIC g189824g0604035818197.jpg GRAPHIC 4451
  Complete submission text file 0001193125-21-182056.txt   174240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kura-20210603.xsd EX-101.SCH 3093
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20210603_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20210603_pre.xml EX-101.PRE 11423
7 EXTRACTED XBRL INSTANCE DOCUMENT d189824d8k_htm.xml XML 3359
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 21994870
SIC: 2834 Pharmaceutical Preparations